SCHEMBL19987642

SCHEMBL19987642

CC1(C)O[C@@H]2O[C@@H]3[C@@H](OC(c4ccccc4)O[C@@H]3CO)[C@@H]2O1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
GLB1 P16278 1/20 0.41
TXNRD1 Q16881 1/20 0.35
TXNRD3 Q86VQ6 1/20 0.35
TXNRD2 Q9NNW7 1/20 0.35
HPGD P15428 2/20 0.33
LMNA P02545 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MEN1 O00255 1/20 0.33
POLB P06746 1/20 0.33
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33
CYP3A4 P08684 1/20 0.32
MAPK1 P28482 1/20 0.32
PI4KA P42356 1/20 0.32
PI4K2B Q8TCG2 1/20 0.32
PI4K2A Q9BTU6 1/20 0.32
PI4KB Q9UBF8 1/20 0.32
CA2 P00918 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18121287 1.00 ALDH1A1 (0.44) ALDH1A1GLB1TXNRD1TXNRD3TXNRD2
SCHEMBL20033544 1.00 ALDH1A1 (0.44) ALDH1A1GLB1TXNRD1TXNRD3TXNRD2
SCHEMBL7987844 1.00 ALDH1A1 (0.44) ALDH1A1GLB1TXNRD1TXNRD3TXNRD2
SCHEMBL7150901 1.00 ALDH1A1 (0.44) ALDH1A1GLB1TXNRD1TXNRD3TXNRD2
SCHEMBL31571169 1.00 ALDH1A1 (0.44) ALDH1A1GLB1TXNRD1TXNRD3TXNRD2
SCHEMBL7991319 1.00 ALDH1A1 (0.44) ALDH1A1GLB1TXNRD1TXNRD3TXNRD2
SCHEMBL7150801 0.88 ALDH1A1 (0.43) ALDH1A1GLB1HPGDMEN1POLB
SCHEMBL11301737 0.85 ALDH1A1 (0.48) ALDH1A1GLB1HPGDMEN1POLB
SCHEMBL18121282 0.85 ALDH1A1 (0.47) ALDH1A1GLB1HPGDMEN1POLB
SCHEMBL7154831 0.83 POLB (0.48) ALDH1A1TXNRD1TXNRD3TXNRD2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10668169-B2 Micelle composition for nucleic acid delivery using temperature-sensitive polymer and method for producing same THE UNIVERSITY OF TOKYO (JP) 2020-06-02 US disclosed
US-20180289835-A1 MICELLE COMPOSITION FOR NUCLEIC ACID DELIVERY USING TEMPERATURE-SENSITIVE POLYMER AND METHOD FOR PRODUCING SAME THE UNIVERSITY OF TOKYO (JP) 2018-10-11 US disclosed
EP-3299020-A1 MICELLE COMPOSITION FOR NUCLEIC ACID DELIVERY USING TEMPERATURE-SENSITIVE POLYMER AND METHOD FOR PRODUCING SAME THE UNIVERSITY OF TOKYO (JP) 2018-03-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10668169-B2 Micelle composition for nucleic acid delivery using temperature-sensitive polymer and method for producing same POLRMT, LEO1, DLST ALDH1A1 4853/4885GLB1 2225/4885TXNRD1 4420/4885
US-20180289835-A1 MICELLE COMPOSITION FOR NUCLEIC ACID DELIVERY USING TEMPERATURE-SENSITIVE POLYMER AND METHOD FOR PRODUCING SAME POLRMT, LEO1, DLST ALDH1A1 4853/4885GLB1 2225/4885TXNRD1 4420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.